Advertisements

TESARO Inc. (TSRO) Stock Quote

Detailed Quote for TESARO Inc. (TSRO)
$ 131.97   2.95 (+2.29%) Volume: 1.7m 4:00 PM EDT Jul 21, 2017
After Hours:  $ 129.09   -2.88 (-2.18%) Volume: 9.86k 4:32 PM EDT Jul 21, 2017
Today 5d 1m 3m 1y more
Last Price
131.97
Change $
2.95
Change %
2.29%
Tick
  
Bid
127.00
Bid Size
100
Ask
142.00
Ask Size
100
Open
129.37
High
137.25
Low
126.83
Prev Close
129.02
Last Trade
07/21/17
Volume
1.7m
52 Wk Hi
192.940002
52 Wk Low
83.2600021
Market Cap
7.11b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
53,864,741
EPS (TTM)
-8.48999977
PE Ratio
N/A
Exchange
NGS
News and Media for TESARO Inc. (TSRO)
Sector News | Topic News
News for TESARO Inc. (TSRO)
Fri, Jul 21, 2017
12:03 PM Tesaro's Stock Dip Is Nothing To Be Afraid Of - SeekingAlpha
Wed, Jul 19, 2017
2:09 PM FDA's Flashing Green Light Boosts Novel Drug Approvals - SeekingAlpha
Thu, Jul 13, 2017
10:10 AM TESARO down 6% on diminished prospects for deal - SeekingAlpha
Wed, Jul 12, 2017
12:09 PM Tesaro Shows Good Potential With Major Approvals This Year - SeekingAlpha
Fri, Jun 30, 2017
7:45 AM OPKO Health Poised For Growth - SeekingAlpha
Thu, Jun 29, 2017
9:00 AM TESARO Joins OCRFA as Presenting Sponsor of the 2017 Ovarian Cancer National Conference - GlobeNewswire
Wed, Jun 28, 2017
11:54 AM Will The Federal Reserve Avoid A Slowdown? - SeekingAlpha
9:00 AM TESARO Announces Lonnie Moulder and Mary Lynne Hedley Named\u00A0EY Entrepreneurs of the Year\u00AE New England - GlobeNewswire
Mon, Jun 26, 2017
4:15 PM TESARO Joins Healthcare Businesswomen's Association as Corporate Partner - GlobeNewswire
1:16 PM Is Clovis Oncology A Takeover Candidate? - SeekingAlpha
Wed, Jun 21, 2017
1:58 PM Biotech's Best Chance Has Gotten Even Better - SeekingAlpha
Tue, Jun 20, 2017
12:56 PM 3 Things In Biotech You Should Learn Today: June 20, 2017 - SeekingAlpha
Mon, Jun 19, 2017
2:20 PM Ariel3 Puts Rubraca On Parp With Zejula - SeekingAlpha
9:12 AM Premarket Losers as of 9:05 am - SeekingAlpha
7:15 AM Clovis' Rubraca improved PFS in patients with advanced platinum-sensitive ovarian cancer in late-stage study; U.S. marketing application within four months; shares ahead 41% premarket - SeekingAlpha
Fri, Jun 16, 2017
1:49 PM Tesaro (TSRO) Presents At Goldman Sachs 38th Annual Global Healthcare Conference - Slideshow - SeekingAlpha
Thu, Jun 15, 2017
3:01 PM TESARO's Zejula grabbing share in ovarian cancer; rival Clovis down 6% - SeekingAlpha
Tue, Jun 13, 2017
1:00 PM Should Gilead Buy Tesaro? - SeekingAlpha
Mon, Jun 12, 2017
12:42 PM Gilead and Sanofi eyeing TESARO - StreetInsider - SeekingAlpha
Fri, Jun 09, 2017
10:44 AM Recruitment suspended in mid-stage study of TESARO's niraparib; shares down 9% - SeekingAlpha
More News for TSRO >>

Tags for TESARO Inc.

Research stocks or mutual funds related to TESARO Inc. by keywords or tags. Find companies that have a similar focus to TSRO. The keywords below have been associated to TSRO by either user submission or electronic means.